Cornerstone Capital Management Holdings LLC. Buys 1,519 Shares of HCA Holdings, Inc. (HCA)
Cornerstone Capital Management Holdings LLC. raised its holdings in HCA Holdings, Inc. (NYSE:HCA) by 2.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 72,383 shares of the company’s stock after acquiring an additional 1,519 shares during the quarter. Cornerstone Capital Management Holdings LLC.’s holdings in HCA were worth $5,760,000 as of its most recent filing with the SEC.
A number of other institutional investors have also added to or reduced their stakes in HCA. Janney Montgomery Scott LLC lifted its holdings in HCA by 0.4% in the second quarter. Janney Montgomery Scott LLC now owns 3,174 shares of the company’s stock valued at $277,000 after acquiring an additional 14 shares during the period. Schwab Charles Investment Management Inc. raised its stake in shares of HCA by 1.2% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 1,066,358 shares of the company’s stock worth $92,987,000 after buying an additional 12,797 shares during the last quarter. First Mercantile Trust Co. raised its stake in shares of HCA by 57.8% during the 2nd quarter. First Mercantile Trust Co. now owns 2,903 shares of the company’s stock worth $253,000 after buying an additional 1,063 shares during the last quarter. LMR Partners LLP acquired a new position in shares of HCA during the 2nd quarter worth $1,461,000. Finally, State of Wisconsin Investment Board raised its stake in shares of HCA by 30.8% during the 2nd quarter. State of Wisconsin Investment Board now owns 249,077 shares of the company’s stock worth $21,720,000 after buying an additional 58,710 shares during the last quarter. 75.35% of the stock is owned by institutional investors.
HCA Holdings, Inc. (NYSE HCA) traded down $1.44 during trading on Friday, reaching $86.15. The company had a trading volume of 1,729,400 shares, compared to its average volume of 2,296,569. The stock has a market cap of $31,011.46, a PE ratio of 13.29, a PEG ratio of 1.29 and a beta of 0.56. HCA Holdings, Inc. has a 1 year low of $71.18 and a 1 year high of $91.03. The company has a current ratio of 1.68, a quick ratio of 1.41 and a debt-to-equity ratio of -6.46.
HCA (NYSE:HCA) last posted its quarterly earnings data on Tuesday, October 31st. The company reported $1.21 EPS for the quarter, hitting analysts’ consensus estimates of $1.21. The firm had revenue of $10.70 billion during the quarter, compared to analysts’ expectations of $10.70 billion. HCA had a negative return on equity of 47.16% and a net margin of 6.13%. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.45 EPS. equities research analysts predict that HCA Holdings, Inc. will post 6.56 EPS for the current fiscal year.
Several research analysts have recently issued reports on the company. Citigroup raised HCA from a “neutral” rating to a “buy” rating in a research note on Tuesday. Robert W. Baird reaffirmed a “buy” rating on shares of HCA in a research note on Thursday, September 28th. ValuEngine raised HCA from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. BMO Capital Markets assumed coverage on HCA in a research note on Monday, October 16th. They set an “outperform” rating and a $90.00 price target for the company. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $90.00 price target on shares of HCA in a research note on Thursday, October 19th. Two analysts have rated the stock with a sell rating, five have given a hold rating and nineteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $90.20.
In other HCA news, insider Michael S. Cuffe sold 2,150 shares of HCA stock in a transaction dated Wednesday, November 22nd. The stock was sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the sale, the insider now owns 12,476 shares in the company, valued at approximately $973,128. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Victor L. Campbell sold 8,000 shares of HCA stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $78.00, for a total value of $624,000.00. Following the completion of the sale, the senior vice president now owns 127,275 shares of the company’s stock, valued at approximately $9,927,450. The disclosure for this sale can be found here. In the last quarter, insiders have sold 20,300 shares of company stock valued at $1,565,960. 2.90% of the stock is currently owned by company insiders.
WARNING: This report was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.watchlistnews.com/cornerstone-capital-management-holdings-llc-buys-1519-shares-of-hca-holdings-inc-hca/1765606.html.
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).
Receive News & Ratings for HCA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA and related companies with Analyst Ratings Network's FREE daily email newsletter.